RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Staidson Beijing BioPharmaceuticals Co - Stock

Staidson Beijing BioPharmaceuticals Co ROE 2024

Staidson Beijing BioPharmaceuticals Co ROE

-0.39

Ticker

300204.SZ

ISIN

CNE100001237

In 2024, Staidson Beijing BioPharmaceuticals Co's return on equity (ROE) was -0.39, a 168.57% increase from the -0.15 ROE in the previous year.

Staidson Beijing BioPharmaceuticals Co Aktienanalyse

What does Staidson Beijing BioPharmaceuticals Co do?

Staidson Beijing BioPharmaceuticals Co Ltd is a leading biopharmaceutical company based in Beijing, China. The company has a long history and a wide range of products and services that make it an important player in the biotechnology field. Staidson Beijing BioPharmaceuticals Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROE Details

Decoding Staidson Beijing BioPharmaceuticals Co's Return on Equity (ROE)

Staidson Beijing BioPharmaceuticals Co's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Staidson Beijing BioPharmaceuticals Co's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Staidson Beijing BioPharmaceuticals Co's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Staidson Beijing BioPharmaceuticals Co’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Staidson Beijing BioPharmaceuticals Co Stock

What is the ROE (Return on Equity) of Staidson Beijing BioPharmaceuticals Co this year?

The ROE of Staidson Beijing BioPharmaceuticals Co this year is -0.39 undefined.

How has the Return on Equity (ROE) of Staidson Beijing BioPharmaceuticals Co developed compared to the previous year?

The ROE of Staidson Beijing BioPharmaceuticals Co has increased by 168.57% increased compared to the previous year.

What impact does a high ROE (Return on Equity) have on investors of Staidson Beijing BioPharmaceuticals Co?

A high ROE indicates that Staidson Beijing BioPharmaceuticals Co generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.

What impact does a low ROE (Return on Equity) have on investors of Staidson Beijing BioPharmaceuticals Co?

A low ROE can indicate that Staidson Beijing BioPharmaceuticals Co is having difficulties monetizing its investments successfully and can be a negative signal for investors.

How does a change in the ROE (Return on Equity) of Staidson Beijing BioPharmaceuticals Co affect the company?

A change in ROE (Return on Equity) of Staidson Beijing BioPharmaceuticals Co can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.

How to calculate the ROE (Return on Equity) of Staidson Beijing BioPharmaceuticals Co?

The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.

Which factors influence the ROE (Return on Equity) of Staidson Beijing BioPharmaceuticals Co?

Some factors that can influence Staidson Beijing BioPharmaceuticals Co's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.

What strategic measures can take to improve the ROE (Return on Equity)?

To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.

How much dividend does Staidson Beijing BioPharmaceuticals Co pay?

Over the past 12 months, Staidson Beijing BioPharmaceuticals Co paid a dividend of 0.67 CNY . This corresponds to a dividend yield of about 11.04 %. For the coming 12 months, Staidson Beijing BioPharmaceuticals Co is expected to pay a dividend of 0 CNY.

What is the dividend yield of Staidson Beijing BioPharmaceuticals Co?

The current dividend yield of Staidson Beijing BioPharmaceuticals Co is 11.04 %.

When does Staidson Beijing BioPharmaceuticals Co pay dividends?

Staidson Beijing BioPharmaceuticals Co pays a quarterly dividend. This is distributed in the months of June, May, April, June.

How secure is the dividend of Staidson Beijing BioPharmaceuticals Co?

Staidson Beijing BioPharmaceuticals Co paid dividends every year for the past 0 years.

What is the dividend of Staidson Beijing BioPharmaceuticals Co?

For the upcoming 12 months, dividends amounting to 0 CNY are expected. This corresponds to a dividend yield of 0 %.

In which sector is Staidson Beijing BioPharmaceuticals Co located?

Staidson Beijing BioPharmaceuticals Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Staidson Beijing BioPharmaceuticals Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Staidson Beijing BioPharmaceuticals Co from 5/17/2019 amounting to 0.668 CNY, you needed to have the stock in your portfolio before the ex-date on 5/17/2019.

When did Staidson Beijing BioPharmaceuticals Co pay the last dividend?

The last dividend was paid out on 5/17/2019.

What was the dividend of Staidson Beijing BioPharmaceuticals Co in the year 2023?

In the year 2023, Staidson Beijing BioPharmaceuticals Co distributed 0 CNY as dividends.

In which currency does Staidson Beijing BioPharmaceuticals Co pay out the dividend?

The dividends of Staidson Beijing BioPharmaceuticals Co are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Staidson Beijing BioPharmaceuticals Co

Our stock analysis for Staidson Beijing BioPharmaceuticals Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Staidson Beijing BioPharmaceuticals Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.